After the landmark Cass review into the care of young people questioning their gender this year, puberty blockers have in effect been banned in England, Wales and Scotland for the treatment of under-18s with gender dysphoria.
Dr Hilary Cass, the report’s author, had criticised the lack of evidence surrounding the benefits and risks associated with the drugs, which delay the onset of puberty.
